Abstract
PurposeTo investigate what effect decreased opioid prescribing following hip arthroscopy had on Press–Ganey satisfaction survey scores.MethodsA retrospective review of prospectively collected data was conducted on patients who underwent primary hip arthroscopy for femoroacetabular impingement between October 2014 and October 2019. Inclusion criteria consisted of complete Press–Ganey survey information, no history of trauma, fracture, connective tissue disease, developmental hip dysplasia, autoimmune disease, or previous hip arthroscopy. Groups were separated based on date of surgery relative to implementation of an institutional opioid reduction policy that occurred in October 2018. Prescriptions were converted to milligram morphine equivalents (MME) for direct comparison between different opioids.ResultsA total of 113 patients met inclusion criteria, 88 preprotocol and 25 postprotocol. There were no statistically significant differences between groups with respect to patient demographics or intraoperative pathologies (P > .05). Average opioid prescription dropped from 249.6 ± 152 MME (equivalent to 33.3 tablets of oxycodone 5 mg) preprotocol to 108.6 ± 84.7 MME (equivalent to 14.5 tablets of oxycodone 5 mg) postprotocol; P = .0002. There were no statistically significant differences in Press–Ganey survey scores between pre- and postprotocol groups (P > .05).ConclusionsA reduction in opioids prescribed after a hip arthroscopy is not associated with any statistically significant difference in patient satisfaction with pain management, as measured by the Press–Ganey survey.Level of EvidenceLevel III, retrospective comparative study.
Highlights
The opioid epidemic was responsible for more than 46,000 deaths in the United States in 2018.1 While awareness and advocacy have increased tremendously, there remain many areas for improvement
The purpose of this study was to investigate what effect decreased opioid prescribing following hip arthroscopy had on PG satisfaction survey scores
The most important finding of this study was that despite opioid-based analgesia being a mainstay of treatment for immediate postoperative pain in patients undergoing hip arthroscopy, a reduction in postoperative prescribing did not result in a statistically significant change in patient satisfaction with pain control
Summary
The opioid epidemic was responsible for more than 46,000 deaths in the United States in 2018.1 While awareness and advocacy have increased tremendously, there remain many areas for improvement. Opioid-based analgesia routinely has been prescribed to manage acute pain after orthopaedic. The PresseGaney (PG) survey is a commonly administered patient satisfaction tool that measures patient perception of care, using similar metrics as the Hospital Consumer. Assessment of Healthcare Providers and Systems survey, which is used as a reimbursement metric by the Value-Based Purchasing program.. Assessment of Healthcare Providers and Systems survey, which is used as a reimbursement metric by the Value-Based Purchasing program.6 These programs place great emphasis on the patient’s perception of care, and pain control remains a major metric in this paradigm.. The purpose of this study was to investigate what effect decreased opioid prescribing following hip arthroscopy had on PG satisfaction survey scores. We hypothesize that patient satisfaction would not change, despite patients being prescribed less opioid pain medication
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
